Literature DB >> 15276473

Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure.

Tong Zhang1, Joan Heller Brown.   

Abstract

Ca2+/calmodulin-dependent protein kinase II (CaMKII), a critical transducer of Ca2+ signaling, is a multifunctional protein kinase which can phosphorylate a wide range of substrates and regulate numerous cellular functions. The delta isoforms of CaMKII predominate in the heart and two splice variants of CaMKIIdelta, deltaB and deltaC, have been demonstrated to be present in the adult mammalian myocardium. The deltaB isoform contains a nuclear localization signal (NLS) that is absent from deltaC, and consequently, the two isoforms have different subcellular localization. Recent work from our laboratory and others has implicated CaMKII in the development of cardiac hypertrophy and heart failure. The specific roles of these CaMKII isoforms in regulating cardiac function appear to be determined by their subcellular localization. The nuclear deltaB isoform plays a key role in hypertrophic gene expression, whereas the cytoplasmic deltaC isoform can affect excitation-contraction (E-C) coupling through phosphorylation of Ca2+ regulatory proteins and may also transduce signals leading to apoptosis. In addition, the nuclear deltaB and the cytoplasmic deltaC isoforms of CaMKII are differentially regulated in pressure overload-induced cardiac hypertrophy. This review focuses on evidence that CaMKII plays an essential role in transcriptional activation associated with cardiac hypertrophy, as well as the aberrant Ca2+ handling and apoptosis that may contribute to heart failure. The hypothesis that CaMKII isoform selective activation, localization and substrate phosphorylation lead to specificity in the resultant signaling pathways is discussed. Copryright 2004 European Society of Cardiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276473     DOI: 10.1016/j.cardiores.2004.04.026

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  110 in total

1.  Ca(2+)/calmodulin-dependent protein kinase II is associated with pelvic pain of neurogenic cystitis.

Authors:  Wenbin Yang; Charles N Rudick; Eneda Hoxha; Stephen A Allsop; Jordan D Dimitrakoff; David J Klumpp
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-30

2.  S-Nitrosylation Induces Both Autonomous Activation and Inhibition of Calcium/Calmodulin-dependent Protein Kinase II δ.

Authors:  Jeffrey R Erickson; C Blake Nichols; Hitoshi Uchinoumi; Matthew L Stein; Julie Bossuyt; Donald M Bers
Journal:  J Biol Chem       Date:  2015-08-27       Impact factor: 5.157

3.  CaMKII inhibition in heart failure, beneficial, harmful, or both.

Authors:  Jun Cheng; Lin Xu; Dongwu Lai; Arnaud Guilbert; Hyun Joung Lim; Thitima Keskanokwong; Yanggan Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

Review 4.  CaMKII, an emerging molecular driver for calcium homeostasis, arrhythmias, and cardiac dysfunction.

Authors:  Chad E Grueter; Roger J Colbran; Mark E Anderson
Journal:  J Mol Med (Berl)       Date:  2006-11-21       Impact factor: 4.599

Review 5.  Protein kinase cascades in the regulation of cardiac hypertrophy.

Authors:  Gerald W Dorn; Thomas Force
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 6.  Remodeling of excitation-contraction coupling in the heart: inhibition of sarcoplasmic reticulum Ca(2+) leak as a novel therapeutic approach.

Authors:  Stefan Neef; Lars S Maier
Journal:  Curr Heart Fail Rep       Date:  2007-03

7.  Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis.

Authors:  Jia Liu; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-15       Impact factor: 4.733

Review 8.  Negative regulation of multifunctional Ca2+/calmodulin-dependent protein kinases: physiological and pharmacological significance of protein phosphatases.

Authors:  A Ishida; N Sueyoshi; Y Shigeri; I Kameshita
Journal:  Br J Pharmacol       Date:  2008-05-05       Impact factor: 8.739

9.  Activation of CaMKIIδA promotes Ca2+ leak from the sarcoplasmic reticulum in cardiomyocytes of chronic heart failure rats.

Authors:  Le Gui; Xin Guo; Zhe Zhang; Hui Xu; Ya-Wei Ji; Ren-Jun Wang; Jiang-Hua Zhu; Qing-Hui Chen
Journal:  Acta Pharmacol Sin       Date:  2018-06-14       Impact factor: 6.150

10.  CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.

Authors:  Scott M MacDonnell; Jutta Weisser-Thomas; Hajime Kubo; Marie Hanscome; Qinghang Liu; Naser Jaleel; Remus Berretta; Xiongwen Chen; Joan H Brown; Abdel-Karim Sabri; Jeffery D Molkentin; Steven R Houser
Journal:  Circ Res       Date:  2009-07-16       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.